Clinical Takeaway Clinical Takeaway: Current randomized controlled trial evidence does not demonstrate established efficacy or safety of cannabinoids as primary treatment for mental disorders or substance use disorders. Existing research gaps mean...
Cannabinoid Clinical Trials: Mental Health Evidence Review
Clinical Takeaway Cannabinoid treatments show limited evidence of efficacy for mental health and substance use disorders in randomized controlled trials, with safety concerns requiring further investigation. Current clinical data does not support...
Cannabinoid Clinical Trials: Mental Disorders Evidence
Clinical Takeaway Clinical Takeaway Current evidence from randomized controlled trials does not support cannabinoids as a primary treatment for mental disorders or substance use disorders. While cannabinoids are often sought for these...
Cannabinoid Clinical Trials for Mental Health Disorders
Clinical Takeaway Cannabinoid treatments show limited evidence for mental disorders and substance use disorders in randomized controlled trials, with efficacy not yet established as primary therapy. Current research does not support cannabinoids...
`Cannabinoid Clinical Trials for Mental and Substance Use Disorders`
Clinical Takeaway Randomized controlled trial evidence reviewed in this meta-analysis does not firmly establish cannabinoids as effective or consistently safe treatments for mental health or substance use disorders. Clinicians should interpret current...
`Cannabinoid Clinical Trials for Mental & Substance Disorders`
Clinical Takeaway Randomized controlled trial evidence for cannabinoids as a primary treatment for mental health or substance use disorders remains limited and inconclusive. Current data do not firmly establish efficacy or a...
A recent study shows Marijuana is not effective for mental health disorders such as anxiety …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Mental HealthAnxietyResearch QualityEvidence-Based MedicineClinical Practice Why This MattersWithout access to the actual study...
Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Mental HealthPsychedelicsDepressionPtsdClinical Trials Why This MattersLarge-scale psychedelic research represents a critical inflection point...
`Cannabinoid Clinical Trials for Mental and Substance Disorders`
Clinical Takeaway Randomized controlled trial evidence reviewed in this meta-analysis examined cannabinoids as a primary treatment for mental health and substance use disorders, assessing both how well they work and how safe...
Cannabinoid Clinical Trials for Mental Health Disorders
Clinical Takeaway Based on randomized controlled trials, the current evidence does not firmly establish cannabinoids as effective primary treatments for mental disorders or substance use disorders. Adverse effects were consistently reported across...